Companion Diagnostics - A perfect storm

Harry Glorikian, Kerry Xie and Jonathan Pan of Scientia Advisors are featured in the January-February 2011 issue of European Biotechnology News with an article on companion diagnostics and the complexity of the personalized medicine environment.

Over the last few years, there has been a tremendous amount of interest in the idea of personalized medicine. Using diagnostic insights to improve the quality and efficiency of healthcare delivered to patients has become a mainstay theme in the field. While diagnostics have long been a part of the physician's armament, we are beginning to see a keen level of excitement mounted by pharmaceutical companies that has been reflected in the increasing number of deals between pharmaceutical and diagnostic companies over the past few years. In addition to these current stakeholders, nontraditional players are emerging who are bringing added complexity to the personalized medicine environment. Entities such as pharmacy benefit managers, hospitals, health IT companies and next-generation sequencing technologies are beginning to become important contributors.

In this article, the authors analyze the movements of current and emerging stakeholders into this dynamic growth environment that is creating what Scientia Advisors calls the "Perfect Storm."

The article can be accessed on the European Biotechnology News website.